- Home
- BMGL vs IAE Comparison
BMGL vs IAE Comparison
Compare BMGL & IAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMGL
- IAE
- Stock Information
- Founded
- BMGL 2001
- IAE 2007
- Country
- BMGL Singapore
- IAE United States
- Employees
- BMGL N/A
- IAE N/A
- Industry
- BMGL
- IAE Trusts Except Educational Religious and Charitable
- Sector
- BMGL
- IAE Finance
- Exchange
- BMGL NYSE
- IAE Nasdaq
- Market Cap
- BMGL 78.3M
- IAE 65.2M
- IPO Year
- BMGL 2025
- IAE N/A
- Fundamental
- Price
- BMGL $6.08
- IAE $6.69
- Analyst Decision
- BMGL
- IAE
- Analyst Count
- BMGL 0
- IAE 0
- Target Price
- BMGL N/A
- IAE N/A
- AVG Volume (30 Days)
- BMGL 11.2M
- IAE 46.3K
- Earning Date
- BMGL 01-01-0001
- IAE 01-01-0001
- Dividend Yield
- BMGL N/A
- IAE 10.21%
- EPS Growth
- BMGL 16.23
- IAE N/A
- EPS
- BMGL 0.09
- IAE N/A
- Revenue
- BMGL $7,428,776.00
- IAE N/A
- Revenue This Year
- BMGL N/A
- IAE N/A
- Revenue Next Year
- BMGL N/A
- IAE N/A
- P/E Ratio
- BMGL $64.62
- IAE N/A
- Revenue Growth
- BMGL 3.32
- IAE N/A
- 52 Week Low
- BMGL $0.91
- IAE $5.31
- 52 Week High
- BMGL $7.18
- IAE $6.45
- Technical
- Relative Strength Index (RSI)
- BMGL N/A
- IAE 72.08
- Support Level
- BMGL N/A
- IAE $6.59
- Resistance Level
- BMGL N/A
- IAE $6.73
- Average True Range (ATR)
- BMGL 0.00
- IAE 0.09
- MACD
- BMGL 0.00
- IAE 0.00
- Stochastic Oscillator
- BMGL 0.00
- IAE 90.48
About BMGL BASEL MEDICAL GROUP LTD
Basel Medical Group Ltd provides general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. Key revenue is generated from Singapore.
About IAE Voya Asia Pacific High Dividend Equity Income Fund ING Asia Pacific High Dividend Equity Income Fund of Beneficial Interest
Voya Asia Pacific High Dividend Equity Income Fund is a United States-based diversified, closed-end fund.The investment objective of the fund is to provide a total return through a combination of current income, capital gains, and capital appreciation. To achieve this objective, under normal market conditions, the fund invests in a portfolio of dividend-yielding equity securities of companies located in the Asia Pacific region.